Robert W. Baird Forecasts Strong Price Appreciation for AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth (NASDAQ:AHCO) had its target price boosted by analysts at Robert W. Baird from $14.00 to $16.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 44.14% from the company’s current price.

Several other research analysts also recently commented on AHCO. Royal Bank of Canada lifted their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a report on Wednesday. UBS Group cut their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Truist Financial lifted their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Canaccord Genuity Group lifted their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Wednesday. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, AdaptHealth has a consensus rating of “Buy” and an average target price of $13.80.

AdaptHealth Trading Up 4.3 %

NASDAQ AHCO opened at $11.10 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth has a twelve month low of $8.35 and a twelve month high of $11.90. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -6.73, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. The business’s fifty day moving average is $9.87 and its 200 day moving average is $10.21.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in AHCO. Pacer Advisors Inc. bought a new position in shares of AdaptHealth in the 4th quarter worth about $76,271,000. Principal Financial Group Inc. raised its position in shares of AdaptHealth by 204.0% in the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock worth $15,735,000 after acquiring an additional 1,109,021 shares in the last quarter. Segall Bryant & Hamill LLC raised its position in shares of AdaptHealth by 29.8% in the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock worth $45,734,000 after acquiring an additional 1,102,173 shares in the last quarter. State Street Corp increased its position in AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after buying an additional 681,816 shares in the last quarter. Finally, FMR LLC increased its position in AdaptHealth by 9.3% in the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after buying an additional 624,645 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.